Probiotics in clinical practice: An overview

Gian Vincento Zuccotti, F. Meneghin, C. Raimondi, D. Dilillo, C. Agostoni, E. Riva, M. Giovannini

Research output: Contribution to journalArticle

46 Citations (Scopus)

Abstract

The observation that intestinal bacterial microflora might be able to influence immune system surveillance through changed nutritional habits has raised awareness of the role of probiotics. These are live microorganisms that are able to reach the gastrointestinal tract and alter its microfloral composition, producing beneficial health effects when consumed in adequate amounts. Recent clinical trials have evaluated the clinical effectiveness of probiotics in the treatment and prevention of a wide range of acute and chronic gastrointestinal diseases, and also non-gastrointestinal diseases, such as atopy, respiratory infections, vaginitis and hypercholesterolaemia. Probiotic supplements are generally regarded as safe because the microorganisms they contain are identical to those found in human gastrointestinal and vaginal microflora. Guidelines on the use of probiotics in the clinical setting require periodical updates for the latest data to be included in clinical applications. The purpose of this clinical report is to review current evidence on the use of probiotics in a variety of gastrointestinal and non-gastrointestinal conditions. Copright

Original languageEnglish
JournalJournal of International Medical Research
Volume36
Issue numberSUPPL. 1
Publication statusPublished - 2008

Fingerprint

Probiotics
Microorganisms
Vaginitis
Gastrointestinal Diseases
Immune system
Hypercholesterolemia
Respiratory Tract Infections
Habits
Gastrointestinal Tract
Immune System
Chronic Disease
Health
Clinical Trials
Guidelines
Chemical analysis
Gastrointestinal Microbiome

Keywords

  • Allergy
  • Clinical effectiveness
  • Clinical trials
  • Evidence level
  • Gastrointestinal diseases
  • Infections
  • Probiotics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Zuccotti, G. V., Meneghin, F., Raimondi, C., Dilillo, D., Agostoni, C., Riva, E., & Giovannini, M. (2008). Probiotics in clinical practice: An overview. Journal of International Medical Research, 36(SUPPL. 1).

Probiotics in clinical practice : An overview. / Zuccotti, Gian Vincento; Meneghin, F.; Raimondi, C.; Dilillo, D.; Agostoni, C.; Riva, E.; Giovannini, M.

In: Journal of International Medical Research, Vol. 36, No. SUPPL. 1, 2008.

Research output: Contribution to journalArticle

Zuccotti, GV, Meneghin, F, Raimondi, C, Dilillo, D, Agostoni, C, Riva, E & Giovannini, M 2008, 'Probiotics in clinical practice: An overview', Journal of International Medical Research, vol. 36, no. SUPPL. 1.
Zuccotti GV, Meneghin F, Raimondi C, Dilillo D, Agostoni C, Riva E et al. Probiotics in clinical practice: An overview. Journal of International Medical Research. 2008;36(SUPPL. 1).
Zuccotti, Gian Vincento ; Meneghin, F. ; Raimondi, C. ; Dilillo, D. ; Agostoni, C. ; Riva, E. ; Giovannini, M. / Probiotics in clinical practice : An overview. In: Journal of International Medical Research. 2008 ; Vol. 36, No. SUPPL. 1.
@article{a94b743fe8e74798a2b4f2cef1bb663f,
title = "Probiotics in clinical practice: An overview",
abstract = "The observation that intestinal bacterial microflora might be able to influence immune system surveillance through changed nutritional habits has raised awareness of the role of probiotics. These are live microorganisms that are able to reach the gastrointestinal tract and alter its microfloral composition, producing beneficial health effects when consumed in adequate amounts. Recent clinical trials have evaluated the clinical effectiveness of probiotics in the treatment and prevention of a wide range of acute and chronic gastrointestinal diseases, and also non-gastrointestinal diseases, such as atopy, respiratory infections, vaginitis and hypercholesterolaemia. Probiotic supplements are generally regarded as safe because the microorganisms they contain are identical to those found in human gastrointestinal and vaginal microflora. Guidelines on the use of probiotics in the clinical setting require periodical updates for the latest data to be included in clinical applications. The purpose of this clinical report is to review current evidence on the use of probiotics in a variety of gastrointestinal and non-gastrointestinal conditions. Copright",
keywords = "Allergy, Clinical effectiveness, Clinical trials, Evidence level, Gastrointestinal diseases, Infections, Probiotics",
author = "Zuccotti, {Gian Vincento} and F. Meneghin and C. Raimondi and D. Dilillo and C. Agostoni and E. Riva and M. Giovannini",
year = "2008",
language = "English",
volume = "36",
journal = "Journal of International Medical Research",
issn = "0300-0605",
publisher = "Field House Publishing LLP",
number = "SUPPL. 1",

}

TY - JOUR

T1 - Probiotics in clinical practice

T2 - An overview

AU - Zuccotti, Gian Vincento

AU - Meneghin, F.

AU - Raimondi, C.

AU - Dilillo, D.

AU - Agostoni, C.

AU - Riva, E.

AU - Giovannini, M.

PY - 2008

Y1 - 2008

N2 - The observation that intestinal bacterial microflora might be able to influence immune system surveillance through changed nutritional habits has raised awareness of the role of probiotics. These are live microorganisms that are able to reach the gastrointestinal tract and alter its microfloral composition, producing beneficial health effects when consumed in adequate amounts. Recent clinical trials have evaluated the clinical effectiveness of probiotics in the treatment and prevention of a wide range of acute and chronic gastrointestinal diseases, and also non-gastrointestinal diseases, such as atopy, respiratory infections, vaginitis and hypercholesterolaemia. Probiotic supplements are generally regarded as safe because the microorganisms they contain are identical to those found in human gastrointestinal and vaginal microflora. Guidelines on the use of probiotics in the clinical setting require periodical updates for the latest data to be included in clinical applications. The purpose of this clinical report is to review current evidence on the use of probiotics in a variety of gastrointestinal and non-gastrointestinal conditions. Copright

AB - The observation that intestinal bacterial microflora might be able to influence immune system surveillance through changed nutritional habits has raised awareness of the role of probiotics. These are live microorganisms that are able to reach the gastrointestinal tract and alter its microfloral composition, producing beneficial health effects when consumed in adequate amounts. Recent clinical trials have evaluated the clinical effectiveness of probiotics in the treatment and prevention of a wide range of acute and chronic gastrointestinal diseases, and also non-gastrointestinal diseases, such as atopy, respiratory infections, vaginitis and hypercholesterolaemia. Probiotic supplements are generally regarded as safe because the microorganisms they contain are identical to those found in human gastrointestinal and vaginal microflora. Guidelines on the use of probiotics in the clinical setting require periodical updates for the latest data to be included in clinical applications. The purpose of this clinical report is to review current evidence on the use of probiotics in a variety of gastrointestinal and non-gastrointestinal conditions. Copright

KW - Allergy

KW - Clinical effectiveness

KW - Clinical trials

KW - Evidence level

KW - Gastrointestinal diseases

KW - Infections

KW - Probiotics

UR - http://www.scopus.com/inward/record.url?scp=39149091048&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=39149091048&partnerID=8YFLogxK

M3 - Article

C2 - 18230282

AN - SCOPUS:39149091048

VL - 36

JO - Journal of International Medical Research

JF - Journal of International Medical Research

SN - 0300-0605

IS - SUPPL. 1

ER -